Involvement of SIK3 in glucose and lipid homeostasis in mice

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Uebi, Tatsuya ^a   Itoh, Yumi ^a   Hatano, Osamu ^b   Kumagai, Ayako ^a,c   Sanosaka, Masato ^a   Sasaki, Tsutomu ^d   Sasagawa, Satoru ^d   Doi, Junko ^e   Tatsumi, Keita ^d   Mitamura, Kuniko ^f   Morii, Eiichi ^d   Aozasa, Katsuyuki ^d   Kawamura, Tomohiro ^d   Okumura, Meinoshin ^d   Nakae, Jun ^g   Takikawa, Hajime ^h   Fukusato, Toshio ^h   Koura, Minako ^a   Nish, Mayumi ^b   Hamsten, Anders ⁱ   Silveira, Angela ⁱ   Bertorello, Alejandro M ⁱ   Kitagawa, Kazuo ^d   Nagaoka, Yasuo ^c   Kawahara, Hidehisa ^c   Tomonaga, Takeshi ^a   Naka, Tetsuji ^a   Ikegawa, Shigeo ^f   Tsumaki, Noriyuki ^d,j   Matsuda, Junichiro ^a   Takemori, Hiroshi ^a   more..

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c KANSAI UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SENRI KINRAN UNIVERSITY   (Japan)

^f KINKI UNIVERSITY   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j KYOTO UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A; ALITRETINOIN; BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; RETINOIC ACID; SALT INDUCIBLE KINASE 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; CHOLELITHIASIS; CHOLESTASIS; CHOLESTEROL METABOLISM; DISEASE ASSOCIATION; DISORDERS OF LIPID METABOLISM; EMBRYO; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; HYPOGLYCEMIA; HYPOLIPEMIA; INSULIN SENSITIVITY; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPODYSTROPHY; LIVER; MALNUTRITION; MOUSE; MOUSE STRAIN; NONHUMAN; NUTRITIONAL STATUS; PHENOTYPE; PROTEIN EXPRESSION;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLIC ACID; DIET, HIGH-FAT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; HYPOGLYCEMIA; LIPID METABOLISM; LIPODYSTROPHY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 84861473712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037803     Document Type: Article

References (61)

1. Wagner M, Zollner G, Trauner M, (2011) Nuclear receptors in liver disease. Hepatology 53: 1023-1034.
2. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, et al. (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9: 1033-1045.
3. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93: 693-704.
4. Kalaany NY, Gauthier KC, Zavacki AM, Mammen PP, Kitazume T, et al. (2005) LXRs regulate the balance between fat storage and oxidation. Cell Metab 1: 231-244.
5. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, et al. (1999) Identification of a nuclear receptor for bile acids. Science 284: 1362-1365.
6. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, et al. (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744.
7. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, et al. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484-489.
8. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, et al. (2011) Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem 286: 26913-26920.
9. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, et al. (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-406.
10. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, et al. (2007) Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 13: 695-702.
11. Iqbal J, Hussain MM, (2009) Intestinal lipid absorption. Am J Physiol Endocrinol Metab 296: E1183-1194.
12. Takemori H, Okamoto M, (2008) Regulation of CREB-mediated gene expression by salt inducible kinase. J Steroid Biochem Mol Biol 108: 287-291.
13. Doi J, Takemori H, Lin X-z, Horike N, Katoh Y, et al. (2002) Salt-inducible kinase represses PKA-mediated activation of human cholesterol side chain cleavage cytochrome promoter through the CREB basic leucine zipper domain. J Biol Chem 277: 15629-15637.
14. Takemori H, Katoh Y, Horike N, Doi J, Okamoto M, (2002) ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase. Implication in the protein kinase A-activated gene transcription in mouse adrenocortical tumor cells. J Biol Chem 277: 42334-42343.
15. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, et al. (2005) The CREB Coactivator TORC2 is a Key Regulator of Fasting Glucose Metabolism. Nature 437: 1109-1111.
16. Uebi T, Tamura M, Horike N, Hashimoto YK, Takemori H, (2010) Phosphorylation of the CREB-specific coactivator TORC2 at Ser(307) regulates its intracellular localization in COS-7 cells and in the mouse liver. Am J Physiol Endocrinol Metab 299: E413-425.
17. Muraoka M, Fukushima A, Viengchareun S, Lombes M, Kishi F, et al. (2009) Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. Am J Physiol Endocrinol Metab 296: E1430-1439.
18. Sasaki T, Takemori H, Yagita Y, Terasaki Y, Uebi T, et al. (2011) SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron 69: 106-119.
19. Horike N, Kumagai A, Shimono Y, Onishi T, Itoh Y, et al. (2010) Downregulation of SIK2 expression promotes the melanogenic program in mice. Pigment Cell Melanoma Res 23: 809-819.
20. Kumagai A, Horike N, Satoh Y, Uebi T, Sasaki T, et al. (2011) A Potent Inhibitor of SIK2, 3, 3′, 7-Trihydroxy-4′-Methoxyflavon (4′-O-Methylfisetin), Promotes Melanogenesis in B16F10 Melanoma Cells. PLoS One 6: e26148.
21. Altarejos JY, Montminy M, (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12: 141-151.
22. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, et al. (2003) TORCs: transducers of regulated CREB activity. Mol Cell 12: 413-423.
23. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, et al. (2003) Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci U S A 100: 12147-12152.
24. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, et al. (2004) The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119: 61-74.
25. Katoh Y, Takemori H, Min L, Muraoka M, Doi J, et al. (2004) Salt-inducible kinase-1 represses cAMP response element-binding protein activity both in the nucleus and in the cytoplasm. Eur J Biochem 271: 4307-4319.
26. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, et al. (2010) Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 120: 4316-4331.
27. Berdeaux R, Goebel N, Banaszynski L, Takemori H, Wandless T, et al. (2007) SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med 13: 597-603.
28. Wang B, Moya N, Niessen S, Hoover H, Mihaylova MM, et al. (2011) A hormone-dependent module regulating energy balance. Cell 145: 596-606.
29. Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, et al. (2006) Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. Febs J 273: 2730-2748.
30. Hashimoto YK, Satoh T, Okamoto M, Takemori H, (2008) Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J Cell Biochem 104: 1724-1739.
31. Sasagawa S, Takemori H, Uebi T, Ikegami D, Hiramatsu K, et al. (2012) SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. Development 139: 1153-1163.
32. Lanjuin A, Sengupta P, (2002) Regulation of chemosensory receptor expression and sensory signaling by the KIN-29 Ser/Thr kinase. Neuron 33: 369-381.
33. Wang B, Goode J, Best J, Meltzer J, Schilman PE, et al. (2008) The insulin-regulated CREB coactivator TORC promotes stress resistance in Drosophila. Cell Metab 7: 434-444.
34. Hurov JB, Huang M, White LS, Lennerz J, Choi CS, et al. (2007) Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo. Proc Natl Acad Sci U S A 104: 5680-5685.
35. Lennerz JK, Hurov JB, White LS, Lewandowski KT, Prior JL, et al. (2010) Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis. Mol Cell Biol 30: 5043-5056.
36. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, et al. (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5: 415-425.
37. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, et al. (2011) Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis. Cell 145: 607-621.
38. Takemori H, Katoh-Hashimoto Y, Nakae J, Olson EN, Okamoto M, (2009) Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts. Endocr J 56: 121-130.
39. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
40. Moschetta A, Bookout AL, Mangelsdorf DJ, (2004) Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 10: 1352-1358.
41. Moschetta A, vanBerge-Henegouwen GP, Portincasa P, Renooij WL, Groen AK, et al. (2001) Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo. J Hepatol 34: 492-499.
42. Gyamfi MA, He L, French SW, Damjanov I, Wan YJ, (2008) Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury. J Pharmacol Exp Ther 324: 443-453.
43. Weiss B, Barshack I, Onaca N, Goldberg I, Berkovich Z, et al. (2010) Vitamin A deficiency associated with enhanced proliferation of bile duct epithelial cells in the rat. Isr Med Assoc J 12: 82-86.
44. Schmidt DR, Holmstrom SR, Fon Tacer K, Bookout AL, Kliewer SA, et al. (2010) Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem 285: 14486-14494.
45. Hoeke MO, Plass JR, Heegsma J, Geuken M, van Rijsbergen D, et al. (2009) Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters. Hepatology 49: 151-159.
46. Elizondo G, Corchero J, Sterneck E, Gonzalez FJ, (2000) Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta. J Biol Chem 275: 39747-39753.
47. Kane MA, Folias AE, Pingitore A, Perri M, Obrochta KM, et al. (2010) Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A 107: 21884-21889.
48. Kane MA, (2012) Analysis, occurrence, and function of 9-cis-retinoic acid. Biochim Biophys Acta 1821 10-20 pp. 10-20.
49. Erickson JM, Mawson AR, (2000) Possible role of endogenous retinoid (Vitamin A) toxicity in the pathophysiology of primary biliary cirrhosis. J Theor Biol 206: 47-54.
50. Kok T, Bloks VW, Wolters H, Havinga R, Jansen PL, et al. (2003) Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 369: 539-547.
51. Chanda D, Lee CH, Kim YH, Noh JR, Kim DK, et al. (2009) Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner. Hepatology 50: 880-892.
52. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, et al. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. Embo J 23: 833-843.
53. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, et al. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642-1646.
54. Woods A, Heslegrave AJ, Muckett PJ, Levene AP, Clements M, et al. (2011) LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice. Biochem J 434: 49-60.
55. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
56. Wu S, Aguilar AL, Ostrow V, De Luca F, (2011) Insulin resistance secondary to a high-fat diet stimulates longitudinal bone growth and growth plate chondrogenesis in mice. Endocrinology 152: 468-475.
57. Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, et al. (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138: 976-989.
58. Maeda T, Jikko A, Abe M, Yokohama-Tamaki T, Akiyama H, et al. (2006) Cartducin, a paralog of Acrp30/adiponectin, is induced during chondrogenic differentiation and promotes proliferation of chondrogenic precursors and chondrocytes. J Cell Physiol 206: 537-544.
59. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, et al. (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142: 296-308.
60. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, et al. (2010) Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142: 309-319.
61. Shikhman AR, Brinson DC, Valbracht J, Lotz MK, (2001) Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 167: 7001-7008.